http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20120124508-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-308 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-428 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-428 |
filingDate | 2011-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2012-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-20120124508-A |
titleOfInvention | Composition for inhibiting multi-drug resistance comprising cheonhwabun extract as an active ingredient |
abstract | The present invention provides a pharmaceutical composition for inhibiting multi-drug resistance, comprising as an active ingredient a cheonhwamin extract excellent in multidrug resistance (MDR) inhibitory ability. The composition of the present invention can overcome the anti-cancer drug resistance seen in multi-drug resistant cells resistant to anti-cancer drugs, and can be used as a pharmaceutically useful composition for inhibiting multi-drug resistance and as an anticancer adjuvant. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021187905-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210117802-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014200261-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10568922-B2 |
priorityDate | 2011-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 142.